Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 8, 2014Comprehensive Clinical Data from Randomized Trials Reviewed
Comprehensive clinical data from randomized trials reviewed
-
Oct 1, 2014
Boston Scientific will webcast its conference call discussing financial results and business highlights for Q3 ended September 30, 2014. Learn how to tune in.
-
Sep 23, 2014Data From REPRISE III Clinical Trial Designed to Support U.S. Regulatory Approval
Data from REPRISE III clinical trial designed to support U.S. regulatory approval
-
Sep 17, 2014Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life
First DBS system to offer precise neural targeting and a 25-year battery life
-
Sep 15, 2014No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year
No cases of moderate or severe paravalvular aortic regurgitation at one year
-
Sep 10, 2014Data Will Focus on Areas of Significant Unmet Patient Need, Including Coronary Artery Disease and Aortic Valve Disease
Data will focus on areas of significant unmet patient need, including Coronary Artery Disease and Aortic Valve Disease
-
Sep 3, 2014
Boston Scientific will participate in the upcoming healthcare conference on September 17, 2014 in London
-
Sep 2, 2014
Acquisition allows Boston Scientific to offer a more complete portfolio of solutions to treat challenging vascular conditions
-
Aug 30, 2014Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure
-
Aug 25, 2014
Boston Scientific will participate in the healthcare conference on September 8 in New York